Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
AMRN

AMRN - Amarin Corp PLC Stock Price, Fair Value and News

0.87USD-0.04 (-4.40%)Delayed

Market Summary

AMRN
USD0.87-0.04
Delayed
-4.40%

AMRN Alerts

  • Big fall in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

AMRN Stock Price

View Fullscreen

AMRN RSI Chart

AMRN Valuation

Market Cap

357.3M

Price/Earnings (Trailing)

-6.79

Price/Sales (Trailing)

1.29

EV/EBITDA

-3

Price/Free Cashflow

277.65

AMRN Price/Sales (Trailing)

AMRN Profitability

EBT Margin

-17.24%

Return on Equity

-9.64%

Return on Assets

-6.66%

Free Cashflow Yield

0.36%

AMRN Fundamentals

AMRN Revenue

Revenue (TTM)

277.5M

Rev. Growth (Yr)

-34.26%

Rev. Growth (Qtr)

-24.35%

AMRN Earnings

Earnings (TTM)

-52.6M

Earnings Growth (Yr)

39.53%

Earnings Growth (Qtr)

-72.17%

Breaking Down AMRN Revenue

Last 7 days

2.4%

Last 30 days

-5.4%

Last 90 days

-28.1%

How does AMRN drawdown profile look like?

AMRN Financial Health

Current Ratio

3.07

Debt/Equity

0.02

Debt/Cashflow

0.14

AMRN Investor Care

Shares Dilution (1Y)

0.85%

Diluted EPS (TTM)

-0.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024277.5M000
2023360.5M346.3M322.4M306.9M
2022535.6M475.6M423.4M369.2M
2021601.2M620.4M605.9M583.2M
2020511.5M546.0M590.1M614.1M
2019258.6M306.7M363.8M429.8M
2018190.4M197.8M205.8M229.2M
2017139.2M151.3M165.9M181.1M
201691.4M106.8M118.0M130.1M
201559.2M64.3M71.6M81.8M
201435.0M42.1M47.8M54.2M
201300026.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Amarin Corp PLC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 31, 2024
berg aaron
acquired
-
-
79,500
evp, president us
Jan 31, 2024
reilly thomas charles
sold (taxes)
-30,444
1.24
-24,552
evp and cfo
Jan 31, 2024
berg aaron
sold (taxes)
-50,619
1.24
-40,822
evp, president us
Jan 31, 2024
ketchum steven b
sold (taxes)
-51,071
1.24
-41,187
chief scientific officer
Jan 31, 2024
reilly thomas charles
acquired
-
-
44,933
evp and cfo
Jan 31, 2024
ketchum steven b
acquired
-
-
79,500
chief scientific officer
Jan 22, 2024
holt patrick
bought
15,724
1.09
14,426
president and ceo
Jan 10, 2024
berg aaron
acquired
-
-
51,500
evp, president us
Jan 10, 2024
berg aaron
sold (taxes)
-27,367
0.97
-28,214
evp, president us
Jan 10, 2024
reilly thomas charles
acquired
-
-
51,500
evp and cfo

1–10 of 50

Which funds bought or sold AMRN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
JANE STREET GROUP, LLC
sold off
-100
-133,810
-
-%
May 16, 2024
Arete Wealth Advisors, LLC
sold off
-100
-9,614
-
-%
May 15, 2024
BARCLAYS PLC
unchanged
-
-
8,000
-%
May 15, 2024
Lido Advisors, LLC
added
11.84
4,265
33,648
-%
May 15, 2024
CAPTRUST FINANCIAL ADVISORS
reduced
-2.41
-13.00
18,056
-%
May 15, 2024
Bayesian Capital Management, LP
sold off
-100
-29,580
-
-%
May 15, 2024
Tower Research Capital LLC (TRC)
reduced
-4.09
-190
10,511
-%
May 15, 2024
AE Wealth Management LLC
sold off
-100
-13,642
-
-%
May 15, 2024
TWO SIGMA SECURITIES, LLC
sold off
-100
-34,810
-
-%
May 15, 2024
Steward Partners Investment Advisory, LLC
reduced
-1.56
110
14,009
-%

1–10 of 47

Are Funds Buying or Selling AMRN?

Are funds buying AMRN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AMRN
No. of Funds

Unveiling Amarin Corp PLC's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Dec 08, 2023
morgan stanley
1.6%
6,427,739
SC 13G/A
Dec 05, 2023
sarissa capital management lp
8.20%
33,470,000
SC 13D/A
Feb 10, 2023
sarissa capital management lp
-
0
SC 13D/A
Dec 12, 2022
baker bros. advisors lp
0.0%
0
SC 13G/A
Oct 11, 2022
sarissa capital management lp
5.95%
2.4e+07
SC 13D/A
Feb 14, 2020
baker bros. advisors lp
9.6%
34,496,685
SC 13G/A

Recent SEC filings of Amarin Corp PLC

View All Filings
Date Filed Form Type Document
May 01, 2024
10-Q
Quarterly Report
May 01, 2024
8-K
Current Report
May 01, 2024
S-8
Employee Benefits Plan
Apr 22, 2024
8-K
Current Report
Apr 19, 2024
4
Insider Trading
Apr 19, 2024
4
Insider Trading
Apr 19, 2024
4
Insider Trading
Apr 19, 2024
4
Insider Trading
Apr 19, 2024
4
Insider Trading
Apr 19, 2024
4
Insider Trading

Peers (Alternatives to Amarin Corp PLC)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
372.2B
85.6B
6.82% -1.69%
9.67
4.35
5.68% 202.39%
332.3B
61.4B
4.65% 15.09%
144.1
5.41
6.11% -82.30%
167.7B
29.5B
18.35% 39.38%
44.55
5.68
12.76% -52.47%
162.3B
57.8B
12.71% -21.46%
129.52
2.81
76.51% -86.81%
84.4B
27.4B
1.23% -13.37%
174.21
3.07
1.51% -91.32%
18.4B
16.0B
23.52% 97.09%
-37.29
1.15
7.23% 71.10%
MID-CAP
4.1B
1.7B
0.67% -19.91%
9.41
2.37
54.01% 364.56%
4.1B
4.6B
-0.70% -10.77%
-528.11
0.89
-0.06% 94.55%
2.5B
9.0B
-21.94% -21.03%
-5.45
0.28
10.01% -27.45%
2.1B
676.2M
8.56% -0.82%
13.75
3.14
30.38% 66.04%
SMALL-CAP
1.5B
743.2M
15.12% -18.85%
-4.35
2.06
24.65% 80.36%
25.8M
1.3M
18.52% -47.17%
-3.49
19.84
-98.14% -104.71%
18.4M
89.6M
6.93% 25.60%
-1.29
0.19
287.27% -129.41%
2.5M
21.5M
2.70% -90.89%
-0.32
0.12
66.16% 61.83%
633.5K
115.7M
-50.00% -97.38%
0
0.01
-2.22% -352.48%

Amarin Corp PLC News

Latest updates
Yahoo News UK • 24 hours ago
Yahoo Singapore News • 13 May 2024 • 06:04 pm
Seeking Alpha • 16 Apr 2024 • 07:00 am
Zacks Investment Research • 4 months ago
Markets Insider • 4 months ago
The Motley Fool • 10 months ago

Amarin Corp PLC Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-24.4%56,519,00074,713,00066,056,00080,167,00085,975,00090,245,00089,878,00094,440,00094,630,000144,491,000142,038,000154,488,000142,170,000167,251,000156,499,000135,317,000154,993,000143,277,000112,408,000100,792,00073,278,000
Gross Profit-29.3%31,904,00045,124,00029,822,00042,668,00047,927,00063,604,00062,859,00043,630,00072,391,000113,856,000111,827,000122,333,000113,844,000132,482,500123,428,000106,520,000120,186,000112,612,00086,964,00078,022,00056,138,000
Operating Expenses-9.0%45,487,00049,961,00051,273,00066,627,00065,268,00073,190,00068,003,000106,462,000100,698,00097,723,000124,900,000113,560,000115,175,000125,324,500130,368,000102,364,000144,215,000107,122,00091,482,00080,536,00078,875,000
  S&GA Expenses-9.2%39,889,00043,941,00045,457,00050,953,00059,587,00068,131,00058,745,00086,893,00090,647,00092,368,000102,965,000107,203,000105,798,000116,816,000120,164,00092,395,000133,937,00096,025,00082,559,00073,406,00071,633,000
  R&D Expenses-3.3%5,598,0005,791,0005,105,0005,642,0005,681,0005,239,0005,765,0009,356,00010,051,0005,753,0007,820,0006,357,0009,377,0008,508,50010,204,0009,969,00010,278,00011,097,0008,923,0007,130,0007,242,000
EBITDA Margin1.4%-0.17-0.17-0.18-0.12-0.25-0.28-0.19-0.19-0.030.020.010.020.01-0.02-0.02-0.04-0.04-0.04-0.18-0.23-0.41
Interest Expenses--------------723,000689,000318,000875,0003,049,000-11,405,0007,273,0007,709,000
Income Taxes-61.0%1,298,0003,332,000501,000-355,0001,964,000-7,629,0001,257,0005,157,0003,213,0001,695,000184,0001,059,000624,0002,674,000430,000--2,359,00077,00016,000--
Earnings Before Taxes-253.4%-8,655,000-2,449,000-18,810,000-17,915,000-14,496,000-6,773,000-3,883,000-64,799,000-28,350,00016,393,000-12,967,0008,867,000-1,002,0007,600,000-6,358,0004,415,000-22,912,0007,232,000-3,462,000-1,820,000-24,431,000
EBT Margin1.4%-0.17-0.17-0.18-0.12-0.25-0.28-0.19-0.19-0.030.020.000.010.01-0.03-0.03-0.03-0.04-0.05-0.17-0.27-0.45
Net Income-72.2%-9,953,000-5,781,000-19,311,000-17,560,000-16,460,000856,000-5,140,000-69,956,000-31,563,00014,698,000-13,151,0007,808,000-1,626,0004,926,000-6,788,0004,415,000-20,553,0007,068,000-3,462,000-1,820,000-24,431,000
Net Income Margin1.6%-0.19-0.19-0.16-0.11-0.25-0.29-0.22-0.21-0.040.010.000.010.00-0.03-0.03-0.02-0.04-0.05-0.17-0.28-0.45
Free Cashflow-1853.6%-12,601,000-645,0007,329,0007,204,000-7,008,0001,552,000-18,213,000-64,584,000-98,847,000-28,240,000-4,540,000-15,053,000-18,704,000-38,323,00010,852,0001,587,0003,886,000-9,300,00020,437,00015,904,000-38,094,000
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-5.0%7908328398608608869089739741,0681,0361,045990966960915926882867390372
  Current Assets-5.1%688725718706684689687719773879963996931879889828817855848372355
    Cash Equivalents7.4%214199271233191218241228219219223327291187207214329645673222211
  Inventory-1.3%25525925522722622922822626823530927223118914912592.0077.0055.0046.0058.00
  Net PPE-28.9%0.000.000.000.000.001.001.001.001.001.002.002.002.002.002.002.002.002.002.001.000.00
Liabilities-12.7%244280286291275291320393333401393400356339353312340274271241231
  Current Liabilities-13.5%224259267271244259287362301371365370326307326283310242230185162
  Long Term Debt-------------------9.0023.0035.00
    LT Debt, Current---------------10.0022.0037.0050.0051.0045.0039.00
    LT Debt, Non Current-------------------9.0023.0035.00
Shareholder's Equity-1.1%546552553569585595588580641667642645635628607603586608596149141
  Retained Earnings-0.6%-1,596-1,586-1,580-1,561-1,543-1,527-1,528-1,522-1,453-1,421-1,436-1,422-1,430-1,429-1,434-1,427-1,431-1,411-1,418-1,414-1,412
  Additional Paid-In Capital0.2%1,9031,8991,8951,8921,8901,8851,8791,8701,8611,8551,8451,8351,8311,8181,7991,7871,7751,7641,7461,3121,301
Shares Outstanding0.5%411409409408407404400398398396397396395382379373361343351331329
Float----485---721---1,710---2,645---6,372-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-1853.6%-12,601-6457,3297,204-7,0081,552-18,213-64,584-98,847-28,240-4,540-15,053-18,704-38,32310,8531,5874,137-8,93621,75015,909-38,089
  Share Based Compensation12.3%5,2184,6473,6081,8355,5566,6124,8778,6466,07810,10210,4322,47913,92511,50811,58312,13110,5918,1887,9637,8836,883
Cashflow From Investing140.4%28,719-70,99930,76734,320-19,610-27,81930,86873,19099,04925,016-99,49150,649127,92923,686-4,359-102,468-293,822-364-1,313--
Cashflow From Financing-1818.1%-1,42683.00-27760.0036438.00-156244-505-196-110426-5,193-5,606-13,292-14,154-25,855-19,316433,400-4,425-47.00
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

AMRN Income Statement

2024-03-31
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Total revenue, net$ 56,519$ 85,975
Less: Cost of goods sold24,61525,794
Less: Cost of goods sold - restructuring inventory012,254
Gross margin31,90447,927
Operating expenses:  
Selling, general and administrative39,88959,587
Research and development5,5985,681
Total operating expenses45,48765,268
Operating loss(13,583)(17,341)
Interest income, net3,3832,221
Other income, net1,545624
Loss from operations before taxes(8,655)(14,496)
Provision for income taxes(1,298)(1,964)
Net loss$ (9,953)$ (16,460)
Loss per share:  
Basic$ (0.02)$ (0.04)
Diluted$ (0.02)$ (0.04)
Weighted average shares:  
Basic410,146406,177
Diluted410,146406,177
Product Revenue, Net  
Total revenue, net$ 55,156$ 84,654
Licensing and Royalty Revenue  
Total revenue, net$ 1,363$ 1,321

AMRN Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:  
Cash and cash equivalents$ 213,944$ 199,252
Restricted cash525525
Short-term investments94,235121,407
Accounts receivable, net115,806133,563
Inventory255,280258,616
Prepaid and other current assets8,14211,618
Total current assets687,932724,981
Property, plant and equipment, net81114
Long-term inventory74,22577,615
Operating lease right-of-use asset7,8768,310
Other long-term assets1,3241,360
Intangible asset, net18,57519,304
TOTAL ASSETS790,013831,684
Current Liabilities:  
Accounts payable67,60052,762
Accrued expenses and other current liabilities154,440204,174
Current deferred revenue2,3412,341
Total current liabilities224,381259,277
Long-Term Liabilities:  
Long-term deferred revenue2,1082,509
Long-term operating lease liability8,3898,737
Other long-term liabilities9,1999,064
Total liabilities244,077279,587
Commitments and contingencies (Note 5)
Stockholders’ Equity:  
Common stock, GBP 0.50 par, unlimited authorized; 421,270,432 shares issued, 410,735,780 shares outstanding as of March 31, 2024; 418,141,295 shares issued, 408,824,093 shares outstanding as of December 31, 2023304,742302,756
Additional paid-in capital1,902,6981,899,456
Treasury stock; 10,534,652 shares as of March 31, 2024; 9,317,202 shares as of December 31, 2023(65,188)(63,752)
Accumulated deficit(1,596,316)(1,586,363)
Total stockholders’ equity545,936552,097
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$ 790,013$ 831,684
AMRN
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
 CEO
 WEBSITEamarincorp.com
 INDUSTRYPharmaceuticals
 EMPLOYEES365

Amarin Corp PLC Frequently Asked Questions


What is the ticker symbol for Amarin Corp PLC? What does AMRN stand for in stocks?

AMRN is the stock ticker symbol of Amarin Corp PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Amarin Corp PLC (AMRN)?

As of Fri May 17 2024, market cap of Amarin Corp PLC is 357.34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMRN stock?

You can check AMRN's fair value in chart for subscribers.

What is the fair value of AMRN stock?

You can check AMRN's fair value in chart for subscribers. The fair value of Amarin Corp PLC is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Amarin Corp PLC is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMRN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Amarin Corp PLC a good stock to buy?

The fair value guage provides a quick view whether AMRN is over valued or under valued. Whether Amarin Corp PLC is cheap or expensive depends on the assumptions which impact Amarin Corp PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMRN.

What is Amarin Corp PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, AMRN's PE ratio (Price to Earnings) is -6.79 and Price to Sales (PS) ratio is 1.29. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMRN PE ratio will change depending on the future growth rate expectations of investors.